Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Profit After Tax: 2019-2024

Historic Profit After Tax for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to -$149.1 million.

  • Caribou Biosciences' Profit After Tax rose 20.57% to -$27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.1 million, marking a year-over-year decrease of 6.09%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • According to the latest figures from FY2024, Caribou Biosciences' Profit After Tax is -$149.1 million, which was down 46.08% from -$102.1 million recorded in FY2023.
  • Caribou Biosciences' Profit After Tax's 5-year high stood at -$34.3 million during FY2020, with a 5-year trough of -$149.1 million in FY2024.
  • Over the past 3 years, Caribou Biosciences' median Profit After Tax value was -$102.1 million (recorded in 2023), while the average stood at -$116.9 million.
  • Data for Caribou Biosciences' Profit After Tax shows a maximum YoY crashed of 95.07% (in 2021) over the last 5 years.
  • Over the past 5 years, Caribou Biosciences' Profit After Tax (Yearly) stood at -$34.3 million in 2020, then slumped by 95.07% to -$66.9 million in 2021, then crashed by 48.56% to -$99.4 million in 2022, then declined by 2.66% to -$102.1 million in 2023, then plummeted by 46.08% to -$149.1 million in 2024.